Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nukhet Aykin-Burns
Univ of Arkansas for Med Scis, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tocol Pharmaceuticals, LLC
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
The Investigator has proprietary interest that is licensed to Tocol Pharmaceuticals, LLC, a (b)(4) equity interest in Tocol Pharmaceuticals, LLC, and performs research that has the potential to affect the value of this interest.
Center for Studies of Host Response to Cancer Therapy
PUBLIC HEALTH RELEVANCE (provided by applicant): Many cancer survivors cured of their original malignancy suffer from treatment-related problems, ranging from mild psychosocial disabilities to life-threatening physical sequelae. Comparatively little effort has been directed toward determining the mechanisms that are responsible for side effects that persist after cancer therapy and at developing effective interventions to prevent them. This COBRE Center addresses these unmet needs and ensures that advances in oncology go hand in hand with efforts to optimize the quality of life of cancer survivors, thereby maximizing the number of uncomplicated cancer cures.
Filed on January 19, 2018.
Tell us what you know about Nukhet Aykin-Burns's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Nukhet Aykin-Burns”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Nukhet Aykin-Burns | Univ of Arkansas for Med Scis | Conflict of Interest | Tocol Pharmaceuticals, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.